Brain injury rehabilitation. 2. Medical rehabilitation of brain injury

Archives of Physical Medicine and Rehabilitation

Volumn 79, Issue 3 SUPPL. 1, 1998, Pages

  O'Dell, Michael W ^a,b   Bell, Kathleen R ^c   Sandel, M Elizabeth ^d  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b South Shore University Hospital Zucker School of Medicine at Hofstra Northwell   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d KAISER FOUNDATION HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; BISPHOSPHONIC ACID DERIVATIVE; BOTULINUM TOXIN; CARBAMAZEPINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; LAMOTRIGINE; METHYLPHENIDATE; NONSTEROID ANTIINFLAMMATORY AGENT; PEMOLINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

AMNESIA; AROUSAL; ATTENTION DEFICIT DISORDER; BRAIN INJURY; CLINICAL TRIAL; HUMAN; HYDROCEPHALUS; INSOMNIA; INTRATHECAL DRUG ADMINISTRATION; LANGUAGE DISABILITY; MUSCULOSKELETAL DISEASE; PHYSICAL MEDICINE; REVIEW; SEIZURE; SPASTICITY; VERTIGO; VISUAL DISORDER;

EID: 0031917398     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(98)90114-9     Document Type: Article

References (45)

1. Yablon SA. Posttraumatic seizures. Arch Phys Med Rehabil 1993;74: 983-1001.
2. Wroblewski BA, McColgan K, Smith K, Whyte J, Singer WD. The incidence of seizures during tricyclic antidepressant drug treatment in a brain-injured population. J Clin Psychopharmacol 1990;10: 124-8.
3. Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497-502.
4. Glantz MJ, Cole BF, Friedberg MH, Lathi E, Choy H, Furie K, et al. A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 1996;46:985-91.
5. Smith KR Jr, Goulding PM, Wilderman D, Goldfader PR, Holterman-Hommes P, Wei F. Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study. Arch Neurol 1994;51:653-60.
6. Meador KJ, Loring DW, Moore EE, Thompson WO, Nichols ME, Oberzan RE, et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology 1995;45: 1494-9.
7. Massagli TL. Neurobehavioral effects of phenytoin, carbamazepine, and valproic acid: implications for use in traumatic brain injury. Arch Phys Med Rehabil 1991;72:219-26.
8. Brailowsky S, Knight RT, Efron R. Phenytoin increases the severity of cortical hemiplegia in rats. Brain Res 1986;376:71-7.
9. Goldstein LB. Commonly prescribed medications and novel pharmacologic approaches in stroke rehabilitation. In: Gorelick PB, editor. Atlas of cerebrovascular disease. Philadelphia: Current Medicine, 1996:23.1-.13.
10. Leach JP, Girvan J, Paul A, Brodie MJ. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiat 1997;62:372-6.
11. Gillham R, Baker G, Thompson P, Birbeck K, McGuire A, Tomlison L, et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of antiepileptic drug treatments. Epilepsy Res 1996;24:47-55.
12. Sandel ME. Medical management of the comatose, vegetative, or minimally responsive patient. NeuroRehabilitation 1996;6:9-17.
13. Long DF. Diagnosis and management of intracranial complications in traumatic brain injury rehabilitation. In: Horn LJ, Zasler ND, editors. Medical rehabilitation of traumatic brain injury. Philadelphia: Hanley & Belfus, 1996:333-62.
14. Marmarou A, Foda MAA, Bandoh K, Yoshihara M, Yamamoto T, Tsuji O, et al. Posttraumatic ventriculomegaly: hydrocephalus or atrophy? A new approach for diagnosis using CSF dynamics. J Neurosurg 1996;85:1026-35.
15. Doherty D. Posttraumatic hydrocephalus. Phys Med Rehabil Clin North Am 1992;3(2):389-405.
16. Vanneste J, Augustijn P, Dirven C, Tan WF, Goedhart ZD. Shunting normal-pressure hydrocephalus: do the benefits outweigh the risks? A multicenter study and literature review. Neurology 1992;42:54-9.
17. Jones RFC, Kwok BCT, Stening WA, Vonau M. Neuroendoscopic third ventriculostomy: a practical alternative to extracranial shunts in non-communicating hydrocephalus. Acta Neurochir (Suppl) 1994;61: 79-83.
18. Whyte J: Attention and arousal: basic science aspects. Arch Phys Med Rehabil 1992;73:940-9.
19. Whyte J: Neurologic disorders of attention and arousal: assessment and treatment. Arch Phys Med Rehabil 1992;73:1094-103.
20. Guilteri CT. Neuropsychiatry and behavioral pharmacology. New York: Springer, 1991.
21. Wroblewski BA, Glenn MB. Pharmacological treatment of arousal and cognitive deficits. J Head Trauma Rehabil 1994;9(3):19-42.
22. Cope DN. Psychopharmacological aspects of traumatic brain injury. In: Horn LR, Zasler ND, editors. Medical rehabilitation of traumatic brain injury. Philadelphia: Hanley & Belfus, 1996:573-612.
23. Goldstein LB. Common drugs may influence motor recovery after stroke. Neurology 1995;45:865-71.
24. Katz RT, editor. Spasticity. Phys Med Rehabil: State of the Art Reviews 1994;8(3).
25. Glenn MB, Whyte J. The practical management of spasticity in children and adults. Philadelphia: Lea & Febiger, 1990:227-58.
26. Gellman H, Keenan MAE, Stone L, Hardy SE, Waters RL, Stewart C. Reflex sympathetic dystrophy in brain injured patients. Pain 1992;51:307-11.
27. Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswod AS, Leon JM, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized double-blind, placebo-controlled trial. Neurology 1996;46:1306-10.
28. Meythaler J, DeVivo MJ, Hadley M. Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury. Arch Phys Med Rehabil 1996;77:461-6.
29. Bontke CF. Medical complications related to traumatic brain injury. Phys Med Rehabil: State of the Art Reviews 1989;3(1):43-58.
30. Djergian RS. Management of musculoskeletal complications. In: Horn LJ, Zasler ND, editors. Medical rehabilitation of traumatic brain injury. Philadelphia: Hanley & Belfus, 1996:459-77.
31. Cosgrove JL, Vargo M, Reidy ME. A prospective study of peripheral nerve injuries occurring in traumatically brain-injured patients. Am J Phys Med Rehabil 1989;68:15-7.
32. Shen JL. Peripheral nerve injury following traumatic brain injury. Phys Med Rehabil: State of the Art Reviews 1993;7(3):503-18.
33. Buschbacher R. Heterotopic ossification: a review. Crit Rev Phys Med Rehabil 1992;4:199-213.
34. Hamilton MG, Hull RD, Pineo GF. Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurg 1994;34: 280-96.
35. Gizzi M. The efficacy of vestibular rehabilitation for patients with head trauma. J Head Trauma Rehabil 1995;10(6):60-77.
36. Herdman SJ, Helminski JO. Vestibular deficits in the head-injured patient. Phys Med Rehabil: State of the Art Reviews 1993;7(3): 559-68.
37. Schlageter K, Gray B, Hall K, Shaw R, Sammet R. Incidence and treatment of visual dysfunction in traumatic brain injury. Brain Inj 1993;7:439-48.
38. Padula WV, Argyis S, Ray J. Visual evoked potentials (VEP) evaluating treatment for post-traumatic vision syndrome (PTVS) in patients with traumatic brain injuries (TBI). Brain Inj 1994;8: 125-33.
39. Cohen AH. Optometric management of binocular dysfunctions secondary to head trauma: case report. J Am Optom Assoc 1992;63: 569-75.
40. Kennedy MRT, Deruyter F.Cognitive and language bases for communication disorders. In: Beukelman DR, Yorkston KM, editors. Communication disorders following traumatic brain injury. Austin, TX:Pro-ed Publishers, 1991:123-90.
41. Gil M, Cohen M, Korn C, Groswasser Z. Vocational outcome of aphasic patient following severe traumatic brain injury. Brain Inj 1996;10:39-45.
42. McDonald S. Communication disorders following closed head injury: new approaches to assessment and rehabilitation. Brain Inj 1992;6:283-92.
43. Small SL. Pharmacotherapy of aphasia: a critical review. Stroke 1994;25:1282-9.
44. Gupta SR, Mlcoch AG, Scolaro C, Moritz T. Bromocriptine treatment of nonfluent aphasia. Neurology 1995;45:2170-3.
45. Sabe L, Salvarezza F, García Cuerva A, Leiguarda R, Starkstein S. A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology 1995;45:2272-4.